XML 18 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Gain (Loss)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Balance as of beginning of the period (in shares)   162,840,360      
Balance as of beginning of the period at Dec. 31, 2022 $ 2,307,745 $ 163 $ 17,358,645 $ (15,008,287) $ (42,776)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options, net (in shares)   78,033      
Exercise of stock options 677   677    
Issuance of common stock upon vesting of restricted stock units (in shares)   1,687,051      
Issuance of common stock upon vesting of restricted stock units 0 $ 2 (2)    
Issuance of stock under employee stock purchase plan (in shares)   271,736      
Issuance of stock under employee stock purchase plan 5,790   5,790    
Stock-based compensation 111,341   111,341    
Other comprehensive income (loss), net of tax 3,996       3,996
Net loss (134,405)     (134,405)  
Balance as of end of the period (in shares) at Jun. 30, 2023   164,877,180      
Balance as of end of the period at Jun. 30, 2023 2,295,144 $ 165 17,476,451 (15,142,692) (38,780)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Balance as of beginning of the period (in shares)   163,919,394      
Balance as of beginning of the period at Mar. 31, 2023 2,291,226 $ 164 17,409,574 (15,077,515) (40,997)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options, net (in shares)   49,906      
Exercise of stock options 381   381    
Issuance of common stock upon vesting of restricted stock units (in shares)   636,144      
Issuance of common stock upon vesting of restricted stock units 0 $ 1 (1)    
Issuance of stock under employee stock purchase plan (in shares)   271,736      
Issuance of stock under employee stock purchase plan 5,790   5,790    
Stock-based compensation 60,707   60,707    
Other comprehensive income (loss), net of tax 2,217       2,217
Net loss (65,177)     (65,177)  
Balance as of end of the period (in shares) at Jun. 30, 2023   164,877,180      
Balance as of end of the period at Jun. 30, 2023 $ 2,295,144 $ 165 17,476,451 (15,142,692) (38,780)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Balance as of beginning of the period (in shares)   164,877,180      
Balance as of beginning of the period (in shares) 166,658,253 166,658,253      
Balance as of beginning of the period at Dec. 31, 2023 $ 2,326,073 $ 167 17,591,551 (15,228,655) (36,990)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options, net (in shares) 247,013 247,013      
Exercise of stock options $ 2,677   2,677    
Issuance of common stock upon vesting of restricted stock units (in shares)   3,915,549      
Issuance of common stock upon vesting of restricted stock units 0 $ 4 (4)    
Issuance of stock under employee stock purchase plan (in shares)   304,068      
Issuance of stock under employee stock purchase plan 3,153   3,153    
Stock-based compensation 91,719   91,719    
Other comprehensive income (loss), net of tax (1,976)       (1,976)
Net loss $ (919,560)     (919,560)  
Balance as of end of the period (in shares) at Jun. 30, 2024 171,124,883 171,124,883      
Balance as of end of the period at Jun. 30, 2024 $ 1,502,086 $ 171 17,689,096 (16,148,215) (38,966)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Balance as of beginning of the period (in shares)   169,314,029      
Balance as of beginning of the period at Mar. 31, 2024 2,288,898 $ 169 17,637,902 (15,310,544) (38,629)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options, net (in shares)   222,941      
Exercise of stock options 2,546   2,546    
Issuance of common stock upon vesting of restricted stock units (in shares)   1,283,845      
Issuance of common stock upon vesting of restricted stock units 0 $ 2 (2)    
Issuance of stock under employee stock purchase plan (in shares)   304,068      
Issuance of stock under employee stock purchase plan 3,153   3,153    
Stock-based compensation 45,497   45,497    
Other comprehensive income (loss), net of tax (337)       (337)
Net loss $ (837,671)     (837,671)  
Balance as of end of the period (in shares) at Jun. 30, 2024 171,124,883 171,124,883      
Balance as of end of the period at Jun. 30, 2024 $ 1,502,086 $ 171 $ 17,689,096 $ (16,148,215) $ (38,966)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Balance as of beginning of the period (in shares) 171,124,883 171,124,883